Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Autoimmune Neurology Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Autoimmune Neurology
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Neurocovid: molecular, cellular, immunological, and clinical insights
Bruno Giometto, MD
07:00 AM - 05:00 PM EDT Abstract 002 - Acute disseminated encephalomyelitis and COVID-19: A Systematic review of Case-Reports and Case-Series
Aminah Abdul Razzack
07:00 AM - 05:00 PM EDT Abstract 003 - SARS-CoV-2 infection: a potential trigger of inflammatory neurological disorders
07:00 AM - 05:00 PM EDT Abstract 004 - Neuro-immunological disorders during the COVID-19 pandemia: an Argentinian hospital based study
Victoria Fernandez
07:00 AM - 05:00 PM EDT Abstract 005 - Unanticipated Improvement of Stiff Person Syndrome after severe COVID-19
Toluwalase O. Tofade, MBBS
07:00 AM - 05:00 PM EDT Abstract 006 - Myelin Oligodendrocyte Glycoprotein (MOG) Antibody associated Disorder following SARS-CoV-2 in a Pediatric Patient
Nusrat Ahsan, MD
07:00 AM - 05:00 PM EDT Abstract 007 - Autoimmune encephalitis following recovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Fawad Yousuf, MBBS
07:00 AM - 05:00 PM EDT Abstract 008 - COVID-19 Associated Facial Diplegia and Lower Extremities Weakness; Subtype of GBS: A Case Report
Vanil Pandya, MD
07:00 AM - 05:00 PM EDT Abstract 009 - SARS-CoV-2 associated Neuromyelitis optica
Tzu-ying Chuang, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 010 - Refractory Acute Disseminated Encephalomyelitis-like Findings in a Pediatric Patient in the Setting of SARS-CoV-2 with Histopathology
Jocelyn B. Lorenzo, MD
07:00 AM - 05:00 PM EDT Abstract 011 - Naive B cells in neuromyelitis optica spectrum disorder: impact of steroid use and relapse occurrence
Marvin Van Luijn
07:00 AM - 05:00 PM EDT Abstract 012 - Relapse Profile Correlates with Treatment Change in NMOSD Patients of the CIRCLES Cohort
Alex Exuzides
07:00 AM - 05:00 PM EDT Abstract 013 - Demographic and Relapse Correlates of Treatment Change in NMOSD Patients: Analysis of the CIRCLES Study
Shervin Gholizadeh
07:00 AM - 05:00 PM EDT Abstract 014 - Correlates of Rituximab Discontinuation in Patients with NMOSD: a CIRCLES Cohort Analysis
Alex Exuzides
07:00 AM - 05:00 PM EDT Abstract 015 - Autologous hematopoietic stem cell transplantation in a pediatric patient with aquaporin-4 neuromyelitis optica spectrum disorder
Tuba Rashid Khan, MD
07:00 AM - 05:00 PM EDT Abstract 016 - Patient Attitudes Towards NMOSD Diagnosis and Treatment: Final Survey Results
Guillermo R. Delgado-Garcia, MD, MSc
07:00 AM - 05:00 PM EDT Abstract 017 - Inebilizumab Treatment Reduces The Occurrence Of Pain In NMOSD Patients
Ho Jin Kim, MD
07:00 AM - 05:00 PM EDT Abstract 018 - QOL associations with disability in Oxford AQP4 NMOSD cohort
NINA EAGLE
07:00 AM - 05:00 PM EDT Abstract 019 - Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder and Concomitant Autoimmune Disease
Anthony Traboulsee, MD
07:00 AM - 05:00 PM EDT Abstract 020 - TRIM46 autoantibody: expanded neurological phenotype and oncological associations
Cristina Valencia Sanchez, MD
07:00 AM - 05:00 PM EDT Abstract 021 - Neurofascin-155 autoimmunity: clinico-pathological associations and outcomes
Shahar Shelly, MD
07:00 AM - 05:00 PM EDT Abstract 022 - Clinical Characteristics of TS-HDS and FGFR3 Antibodies in Chronic Inflammatory Neuropathies
Ylec M. Cardenas Castillo, MD
07:00 AM - 05:00 PM EDT Abstract 023 - Seropositive Pediatric Autoimmune Encephalitis: A Single Center Experience
Praveen Hariharan, MD
07:00 AM - 05:00 PM EDT Abstract 024 - An Autopsy Case of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
Mai Yamakawa, MD
07:00 AM - 05:00 PM EDT Abstract 025 - CASPR2-IgG associated Autoimmune Seizures and Epilepsy
Emilio R. Garrido Sanabria, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 026 - LGI1 encephalitis associated hyponatremia, is it all in the brain?
Avi Gadoth, MD
07:00 AM - 05:00 PM EDT Abstract 027 - Electroencephalographic findings in anti-leucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review
Katrina Roberto, MD
07:00 AM - 05:00 PM EDT Abstract 028 - Clinical and Imaging Characteristics of Non-paraneoplastic Cerebellar Ataxia Associated with Anti-metabotropic Glutamate Receptor Type 1 Autoantibodies
Nobuaki Yoshikura, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 029 - Neuronal uptake, antibody binding, and injury by anti-Ma2 antibodies in organotypic culture of rat brain: a possible role for anti-Ma2 antibody in production of neurological disease
Jonathan R. Galli, MD
07:00 AM - 05:00 PM EDT Abstract 030 - Utilization of Routine Biomarkers for Prediction of an Infectious or Autoimmune Etiology in Encephalitis
Hai Ethan Hoang, MD
07:00 AM - 05:00 PM EDT Abstract 031 - Autoimmune encephalitis antibody biomarkers: Frequency, age and sex associations
Amy Kunchok, MBBS
07:00 AM - 05:00 PM EDT Abstract 032 - Utility of Intrathecal Methotrexate in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis
James E. Eaton III, MD
07:00 AM - 05:00 PM EDT Abstract 033 - The importance and clinical significance of tissue based immunofluorescence antibody testing in the evaluation of autoimmune/paraneoplastic neurological syndromes
Avi Gadoth, MD
07:00 AM - 05:00 PM EDT Abstract 034 - Autoantibody screening using an in-house tissue-based assay facilitates prompt induction of immunotherapy for autoimmune encephalitis
Makoto Hara, MD
07:00 AM - 05:00 PM EDT Abstract 035 - Sleep disorders in anti-LGI1 encephalitis
07:00 AM - 05:00 PM EDT Abstract 036 - Psychiatric and Cognitive Profile in the Post-Acute Stage of Anti-NMDA Receptor Encephalitis: A Comparative Analysis with Patients with Schizophrenia.
07:00 AM - 05:00 PM EDT Abstract 037 - Does the NEOS Score Predict Outcomes in Pediatric Anti-NMDA Receptor Encephalitis Patients?
Leah Loerinc
07:00 AM - 05:00 PM EDT Abstract 038 - Anti-NMDA Receptor Encephalitis and Brain Volume Loss in Children
Frederick Bassal, DO
07:00 AM - 05:00 PM EDT Abstract 039 - Tofacitinib treatment in refractory autoimmune encephalitis
Yoonhyuk Jang, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 040 - A Multi-center Case Series of Sarcoid Optic Neuropathy
Lauren M. Webb, MD
07:00 AM - 05:00 PM EDT Abstract 041 - Clinical Profile Of Neurological Manifestations In Patients With Rheumatological Diseases
Akshay Deepak, MD
07:00 AM - 05:00 PM EDT Abstract 042 - Unilateral Relapsing PACNS: an entity suggesting different immune response between the cerebral hemispheres
Mahmoud A. AbdelRazek, MD
07:00 AM - 05:00 PM EDT Abstract 043 - Mortality associated with Myelopathy and Transverse Myelitis in the National US Veterans Affairs Health Administration
Justin Abbatemarco, MD
07:00 AM - 05:00 PM EDT Abstract 044 - Myelopathy in the Setting of Malignancy: The Importance of a Thoughtful Approach to Autoantibody Testing Based on Clinical Presentation
Stefanie J. Rodenbeck, MD
07:00 AM - 05:00 PM EDT Abstract 045 - Pembrolizumab-Associated Encephalitis in Advanced Non-Small Cell Lung Cancer
Martineau Louine, MD
07:00 AM - 05:00 PM EDT Abstract 046 - Update on clinical and serological presentations of immune checkpoint inhibitor-related neuropathies in the context of expanding indications of cancer immunotherapy.
Pitcha Chompoopong, MD
07:00 AM - 05:00 PM EDT Abstract 047 - Case series of hypertrophic pachymeningitis with underlying etiology
Maria Camila Moreno Escobar, MD
07:00 AM - 05:00 PM EDT Abstract 048 - Acute Ischemic Stroke in the Setting of Acute Posterior Multifocal Placoid Pigment Epitheliopathy
Leila Ghaffari, MD
07:00 AM - 05:00 PM EDT Abstract 049 - An overlap syndrome: Myositis specific and Myositis associated antibodies in dermatomyositis
Sarah Germaine, DO
07:00 AM - 05:00 PM EDT Abstract 050 - Interleukin-6 Inhibition with Tocilizumab for Relapsing MOG-IgG Associated Disorder
Paul M. Elsbernd, MD
07:00 AM - 05:00 PM EDT Abstract 051 - Efficacy of Mycophenolate Mofetil in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review and Meta-analysis
Smathorn Thakolwiboon, MD
07:00 AM - 05:00 PM EDT Abstract 052 - MRI Characterization of Damage in and Around Lesions in Pediatric MS and MOG-associated disorders
Robert A. Brown, PhD
07:00 AM - 05:00 PM EDT Abstract 053 - Axonal and myelin volume fractions and imaging g-ratio in pediatric MS and MOG-associated disorders.
Giulia Longoni, MD
07:00 AM - 05:00 PM EDT Abstract 054 - Combined central and peripheral nervous system demyelination: an unusual presentation of MOG antibody disorder
Jasmin Patel, MD
07:00 AM - 05:00 PM EDT Abstract 055 - Overlapping Demyelinating Syndrome Associated with Myelin Oligodendrocyte Glycoprotein Antibody and Anti-N-methyl-d-aspartate Receptor Encephalitis
Valerie Jeanneret Lopez, MD
07:00 AM - 05:00 PM EDT Abstract 056 - A Review of Pediatric Demyelinating Disorders to Determine the Clinical Presentation and Imaging Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody Disease
Jeffrey Varghese
07:00 AM - 05:00 PM EDT Abstract 057 - MOG-Abs in CSF only: pathological findings support the diagnostic role
Sara Carta, MD
07:00 AM - 05:00 PM EDT Abstract 058 - Optic Chiasma involvement in Anti MOG- Antibody Syndrome.
Saba Asif, MBBS
07:00 AM - 05:00 PM EDT Abstract 059 - Atypical Clinical Course of Anti-MOG Disease With Recurrent ADEM-like Presentation
Amal Atrous, Jr.
07:00 AM - 05:00 PM EDT Abstract 060 - Performance Characteristics of a Radioimmunoprecipitation Assay for the Detection of Ganglionic Acetylcholine Receptor Antibodies
Lisa K. Peterson, PhD
07:00 AM - 05:00 PM EDT Abstract 061 - All-cause Mortality in Patient with Chronic Inflammatory Demyelinating Polyneuropathy after Immunomodulatory Therapy versus No Treatment
Keyvan Heshmati, MD
07:00 AM - 05:00 PM EDT Abstract 062 - Real-World Use of Eculizumab in Generalized Myasthenia Gravis in the United States: Results From a Pilot Retrospective Chart-Review Study
Srikanth Muppidi, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 063 - Patient and Treatment Characteristics of a Large US Sample of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) Therapy
07:00 AM - 05:00 PM EDT Abstract 064 - The Lived Experience of Myasthenia Gravis (MG): A Patient-led Analysis
Nancy Law
07:00 AM - 05:00 PM EDT Abstract 065 - Phase 3 Study of Facilitated Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Interim Analysis of Immunogenicity
Shabbir Hasan
07:00 AM - 05:00 PM EDT Abstract 066 - Characterization of Spasm-Related Respiratory Impairment in Stiff Person Syndrome Spectrum Disorders
Daniela A. Pimentel Maldonado, MD, MSCR
07:00 AM - 05:00 PM EDT Abstract 067 - The Evolving Spectrum of Gastrointestinal Dysfunction in Stiff Person Syndrome
Jacqueline Koshorek, DO
07:00 AM - 05:00 PM EDT Abstract 068 - Immunotherapy in Stiff Person Syndrome, is Timing Really Important?
Maria I. Reyes-Mantilla, MD
07:00 AM - 05:00 PM EDT Abstract 069 - Epilepsia Partialis Continua & Stiff Person Syndrome Occurring Together in a Child with Anti-GAD Antibody Positivity
Aditi V. Varma-Doyle, MD
07:00 AM - 05:00 PM EDT Abstract 070 - Musicogenic Epilepsy: Expanding the Spectrum of GAD65 Neurological Autoimmunity
Kelsey M. Smith, MD
07:00 AM - 05:00 PM EDT Abstract 071 - Longitudinal, Prospective Analysis of Neuronal Injury Biomarkers in a Patient with Paraneoplastic Anti-CRMP5 Antibody Transverse Myelitis with Associated Treatment Response
Christopher S. Mizenko
07:00 AM - 05:00 PM EDT Abstract 072 - Autoimmune Encephalitis: Modifiable and Non-modifiable Predictors of Relapse
Megan A. Hansen, MD
07:00 AM - 05:00 PM EDT Abstract 073 - Clinical and imaging features of idiopathic cerebellar ataxia with anti-cerebellar antibodies
Akira Takekoshi
07:00 AM - 05:00 PM EDT Abstract 074 - Anti LGI1 Encephalitis–A Retrospective Analysis of Clinical Features and Treatment Response
Suresh Chandran, MD
07:00 AM - 05:00 PM EDT Abstract 075 - A Case of Thymoma Associated with Five Paraneoplastic Syndromes and Nine Autoantibodies
Meryim Poursheykhi, MD
07:00 AM - 05:00 PM EDT Abstract 076 - IgLON5 Autoimmunity Syndrome Responsive to Immunotherapy
John C. Feemster, MD
07:00 AM - 05:00 PM EDT Abstract 077 - First Reported Case of a Patient With Anti-IgLON5 Antibody-positive Corticobasal Syndrome
Kimiharu Fuseya
07:00 AM - 05:00 PM EDT Abstract 078 - Electroencephalogram Characteristics including Delta Brush and Predictor of Prognosis in Pediatric Anti-NMDA Receptor Encephalitis
Jenny Lin, MD
07:00 AM - 05:00 PM EDT Abstract 079 - Autoimmune epilepsy, a rare diagnosis, or an underdiagnosed condition?
Khaled Abdalla, MD
07:00 AM - 05:00 PM EDT Abstract 080 - Mycoplasma auto-immune mediated encephalitis
Mohamed Diyab, MD, MBBS
07:00 AM - 05:00 PM EDT Abstract 081 - Immunoglobulin for Co-existing Chronic Autoimmune Autonomic Ganglionopathy and Neuropathy
Marian P. LaMonte, MD, MSN, FAAN
07:00 AM - 05:00 PM EDT Abstract 082 - A Rare Combination of Limbic Encephalitis and Stiff Person Syndrome Separated by Several Years in a Patient with Anti-Glutamic Acid Decarboxylase Antibodies
Travis R. Kooima, MD
07:00 AM - 05:00 PM EDT Abstract 083 - Anti-ITPR1 Encephalopathy in a Patient with Lymphoma
Kevin J. Kyle, MD
07:00 AM - 05:00 PM EDT Abstract 084 - Presence of VGKC complex: CASPR2 / LGI1 antibodies in hydrocele fluid in Morvan's syndrome
Sanjay Sharma, MD
07:00 AM - 05:00 PM EDT Abstract 085 - Changes the Transcriptional Activity of Genes Regulating Neurogenesis in the Blood of Patients with Thyroid Endocrine Pathology
Iryna I. Bilous, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 086 - A Case of Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM syndrome) in a Patient with Myasthenia Gravis
Xing Dai, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Late Onset Anti-NMDA Receptor Auto-Immune Encephalitis In A Patient With A Double Lung Transplant
Elochukwu Ibekwe, MD
07:00 AM - 05:00 PM EDT Abstract 088 - Cortical Venous Thrombosis as the Presenting Symptom of Hugh-Stovin Syndrome
Austin T. Momii, MD
07:00 AM - 05:00 PM EDT Abstract 089 - A Case of Autoimmune GFAP Astrocytopathy
Mariana Vinokur, DO
07:00 AM - 05:00 PM EDT Abstract 090 - A High Number of Relapses and a Delay in Immunosuppressive Therapy are Predictors of Poor Visual Outcomes in LATAM Patients with First-ever NMOSD-related Optic Neuritis
Guillermo R. Delgado-Garcia, MD, MSc
07:00 AM - 05:00 PM EDT Abstract 091 - Disease Phenotype Correlates with Treatment Change in NMOSD Patients of the CIRCLES Cohort
Shervin Gholizadeh
07:00 AM - 05:00 PM EDT Abstract 092 - Early Combination Immunotherapy for Successful Treatment of a Severe Case of Neuromyelitis Optica Spectrum Disorder with Diencephalic Lesions
Victor Wang, MD
07:00 AM - 05:00 PM EDT Abstract 093 - Brainstem encephalitis: case series, approach to the differential diagnosis and review
James E. Eaton III, MD
07:00 AM - 05:00 PM EDT Abstract 094 - Clinical Features of LGI-1 Antibodies Positive Encephalitis with Faciobrachial Dystonic Seizures Turning to the Counterpart Side.
Hiroya Ohara, MD
07:00 AM - 05:00 PM EDT Abstract 095 - Encephalopathy after Gardasil Vaccination: A Vaccine Adverse Event Reporting System Study 2006-2019
07:00 AM - 05:00 PM EDT Abstract 096 - Encephalitis after Influenza Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1990-2018
Nour Jedidi
07:00 AM - 05:00 PM EDT Abstract 097 - Antibodies to CNTN1/CASPR1 complex in a relapsing-remitting immune-mediated neuropathy: An indolent, atypical history, expanding the phenotype.
Rob Durcan, MB, BCh, BAO
07:00 AM - 05:00 PM EDT Abstract 098 - A Case of Leber’s Plus Causing Recurrent Myelopathy Due to a Mutation at G3635A
Elijah Lackey, MD
07:00 AM - 05:00 PM EDT Abstract 099 - Phantosmia associated with Anti-Phospholipid Antibody Syndrome
Alexis E. Brantley
07:00 AM - 05:00 PM EDT Abstract 100 - The mGluR1 Antibody Syndrome: A Potential Mimicker of the Miller Fisher Syndrome (MFS)
Bryan E. Tsao, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 101 - Anti-mitochondrial M2 antibody-positive myositis mimicking amyotrophic lateral sclerosis
Takuya Kudo
07:00 AM - 05:00 PM EDT Abstract 102 - Progressive Multifocal Leukoencephalopathy with Negative CSF PCR for JC Virus in an Immunocompetent Patient with Discoid Lupus
Justin Abbatemarco, MD
07:00 AM - 05:00 PM EDT Abstract 103 - Paraneoplastic Autoimmune Encephalitis Due To Amphiphysin Antibodies Manifesting As Focal Seizures With Convulsive Status Epilepticus In a Patient With Small Cell Lung Carcinoma
Gina S. Perez-Giraldo, MD
07:00 AM - 05:00 PM EDT Abstract 104 - Autoimmune encephalitis with Anti-Glutamic Acid Decarboxylase Antibodies preceded by Herpes Simplex Virus Encephalitis
Dylan T. Warfield, MD
07:00 AM - 05:00 PM EDT Abstract 105 - Chromosomally-Integrated Human Herpes Virus 6 (HHV-6) and Recurrent Aseptic Meningoencephalitis: A Diagnostic Challenge
07:00 AM - 05:00 PM EDT Abstract 106 - Migraine-like Prodrome Preceding New Onset Refractory Status Epilepticus (NORSE) Due to Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in a Child
Ahmad Mahadeen, MD
07:00 AM - 05:00 PM EDT Abstract 107 - Association Between Paraneoplastic Rhombencephalitis and Hypertrophic Olivary Degeneration
Ajay Madhavan
07:00 AM - 05:00 PM EDT Abstract 108 - Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon
Reuben Beer, MBBS
07:00 AM - 05:00 PM EDT Abstract 109 - COVID-19 Associated Acute Disseminated Encephalomyelitis in Adult
Shivani Naik, MD
07:00 AM - 05:00 PM EDT Abstract 110 - A Case of Atypical Neurological Manifestations Associated with Ganglionic Nicotinic Acetylcholine Receptor (a3-AChR) Autoantibody
Melody Badii, MD
07:00 AM - 05:00 PM EDT Abstract 111 - Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) Associated with Systemic T-Cell Lymphoma Responsive to Mycophenolate Mofetil
Dev Mehta, DO
07:00 AM - 05:00 PM EDT Abstract 112 - Post-Traumatic Progressive Myelopathy Presenting with Longitudinally Extensive Transverse Myelitis Following a Penetrating Stab Wound
LynnMarie Jarratt, MD
07:00 AM - 05:00 PM EDT Abstract 113 - Anti-IgLON5 Encephalopathy—A Case Report
Alison Kostandy, MD
07:00 AM - 05:00 PM EDT Abstract 114 - Case of GFAP astropathy associated with enterovirus encephalitis or COVID-19 Infection?
Mariyam Humayun, MD
07:00 AM - 05:00 PM EDT Abstract 115 - Iatrogenic Compressive Thoracic Myelopathy Due to Spinal Epidural Lipomatosis: Steroid a Two-Edge Sword in Neurosarcoidosis
Maria Shoaib, MD
07:00 AM - 05:00 PM EDT Abstract 116 - Anti-mGluR1 Mediated Cerebellar Ataxia Case Report & review of literature
Osama Khojah
Faculty Disclosures
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
No disclosure on file
Karl Krecke Karl Krecke has nothing to disclose.
Richard D. King, MD, PhD, FAAN Dr. King has nothing to disclose.
Vanessa Daccach Marques Vanessa Daccach Marques has nothing to disclose.
Tamour Khan Tareen, MD, MBBS Dr. Tareen has nothing to disclose.
Alison Kostandy, MD Dr. Quan has nothing to disclose.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Sundar Shanmugam, MD Dr. Shanmugam has nothing to disclose.
Grigorios Kalaitzidis, MD Mr. Kalaitzidis has nothing to disclose.
Mariana Vinokur, DO Dr. Vinokur has nothing to disclose.
Masako Kinoshita, MD, PhD Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co. Ltd. . Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo Company, Limited..
Matthew Burford, MD The institution of Dr. Burford has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Burford has received research support from Pharnext Inc.
Eliezer Katz, MD Dr. Katz has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Katz has received stock or an ownership interest from Viela Bio/Horizon Therapeutics.
Kon Chu No disclosure on file
Gregory D. Cascino, MD, FAAN Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Florencia Aguirre No disclosure on file
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Paul D. Crane, MD Dr. Crane has nothing to disclose.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Travis R. Kooima, MD Mr. Kooima has nothing to disclose.
Prashant Natteru, MBBS Dr. Natteru has nothing to disclose.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Jose J. Flores-Rivera, MD Dr. Flores-Rivera has nothing to disclose.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Hamza Coban, MD Dr. Coban has nothing to disclose.
David L. Gordon, MD, FAHA, FAAN Dr. Gordon has nothing to disclose.
Andrew Knight No disclosure on file
Takuya Kudo Takuya Kudo has nothing to disclose.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
Hera A. Kamdar, MD Dr. Kamdar has nothing to disclose.
Eric C. Lawson, MD Dr. Lawson has nothing to disclose.
Julia O'Mahony Ms. O'Mahony has nothing to disclose.
Lauren M. Webb, MD Dr. Webb has nothing to disclose.
John Chen No disclosure on file
Nefize Turan, MD Dr. Turan has nothing to disclose.
Haatem M. Reda, MD Dr. Reda has nothing to disclose.
Gabriel R. Arismendi, MD Dr. Arismendi has nothing to disclose.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Nathalie Jette, MD, MSc, FRCPC, FAAN Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Bertrand P. Tseng, MD, PhD Dr. Tseng has nothing to disclose.
Claire Ruane Ms. Ruane has nothing to disclose.
Jacqueline Koshorek, DO Dr. Koshorek has nothing to disclose.
Sahil Naik, MD Dr. Naik has nothing to disclose.
Evgeny Sidorov, MD Dr. Sidorov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Sidorov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioHaven .
Juan Pablo Pettinicchi, MD No disclosure on file
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Markus Reindl, PhD The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Megan Behne Ms. Behne has received personal compensation for serving as an employee of The Guthy-Jackson Charitable Foundation. Ms. Behne has received personal compensation in the range of $50,000-$99,999 for serving as a Independent Contractor with The Guthy-Jackson Charitable Foundation.
Elson L. So, MD, FAAN Dr. So has nothing to disclose.
Shabbir Hasan Shabbir Hasan has received stock or an ownership interest from Takeda.
JOSELYN ELIZABETH MIÑO ZAMBRANO, MD Dr. MIÑO ZAMBRANO has nothing to disclose.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ian L. Dimaandal, MD Dr. Dimaandal has nothing to disclose.
John R. Mills, MD, PhD The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Clotilde Hainline, MD Dr. Hainline has nothing to disclose.
Giulia Longoni, MD Dr. Longoni has nothing to disclose.
Christopher McGuigan, MD Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. McGuigan has received research support from Biogen. The institution of Dr. McGuigan has received research support from Novartis. The institution of Dr. McGuigan has received research support from Roche.
Ajay Madhavan No disclosure on file
Sarosh R. Irani, MD, PhD, FRCP, FEAN Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Meghan C. Romba, MD Dr. Romba has nothing to disclose.
Michael Ebbert, MD Dr. Ebbert has nothing to disclose.
Deepak K. Lachhwani, MD, FAAN The institution of Dr. Lachhwani has received research support from ICON Clinical Research LLC.
Shailesh Chavan Shailesh Chavan has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Shailesh Chavan has received stock or an ownership interest from Takeda Pharmaceuticals.
Michael J. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Sara Mariotto, MD, PhD Dr. Mariotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, TSF, Dynamics. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF.
Michael R. Yeaman, PhD Dr. Yeaman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech-Roche. Dr. Yeaman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Yeaman has received research support from National Institutes of Health. The institution of Dr. Yeaman has received research support from U.S. Department of Defense. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care. Dr. Yeaman has received intellectual property interests from a discovery or technology relating to health care.
Adrian I. Espiritu, MD Dr. Espiritu has nothing to disclose.
Nour Jedidi Nour Jedidi has nothing to disclose.
Taha Gholipour, MD Dr. Gholipour has nothing to disclose.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Elia Pestana-Knight No disclosure on file
Liang Wang, MD Dr. Wang has nothing to disclose.
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Makoto Hara, MD Dr. Hara has nothing to disclose.
Kit Mui, MD Dr. Mui has nothing to disclose.
Maria Camila Moreno Escobar, MD Dr. Moreno Escobar has nothing to disclose.
Shervin Gholizadeh Mr. Gholizadeh has received personal compensation for serving as an employee of Genentech.
Kevin J. Kyle, MD Dr. Kyle has nothing to disclose.
Orna Aizenstein Lehavi No disclosure on file
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Jeffrey W. Britton, MD, FAAN Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Parisorn Thepmankorn Ms. Thepmankorn has received personal compensation for serving as an employee of Johnson and Johnson.
Robert A. Brown, PhD Dr. Brown has received stock or an ownership interest from ShadowLab Research Inc.. Dr. Brown has received intellectual property interests from a discovery or technology relating to health care. Dr. Brown has a non-compensated relationship as a consultant with the Population Council that is relevant to AAN interests or activities.
Pratibha Surathi, MD Dr. Surathi has nothing to disclose.
Giovanna Manzano, MD Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN Dr. Srinivasan has nothing to disclose.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Siddharama Pawate, MD The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Sean Connolly, MD, MRCPI Dr. Connolly has received publishing royalties from a publication relating to health care.
Jasmin Patel, MD Dr. Patel has nothing to disclose.
Chloe S. Sader, PharmD Chloe Sader has received personal compensation for serving as an employee of Alexion. Chloe Sader has received stock or an ownership interest from Alexion.
Yang Mao-Draayer, MD Dr. Mao-Draayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizone . Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Mao-Draayer has received research support from NIH . The institution of Dr. Mao-Draayer has received research support from Genzyme-Sanofi. The institution of Dr. Mao-Draayer has received research support from Novartis. The institution of Dr. Mao-Draayer has received research support from Genentech.
Michael Waltz No disclosure on file
Guillermo R. Delgado-Garcia, MD, MSc Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Robert G. Smith, MD, PhD Dr. Smith has nothing to disclose.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Khaled Abdalla, MD Dr. Abdalla has nothing to disclose.
Guojun N. Zhang, MD Dr. Zhang has nothing to disclose.
Brenda Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Jessica Robinson Papp, MD, FAAN Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immgenuity Inc. Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropathix Inc. The institution of Dr. Robinson Papp has received research support from NIH. Dr. Robinson Papp has received publishing royalties from a publication relating to health care.
Hideto Nakajima, MD No disclosure on file
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Akira Takekoshi Akira Takekoshi has nothing to disclose.
Veronica A. Tkachuk Veronica A. Tkachuk has nothing to disclose.
Natalia Gonzalez Caldito, MD Dr. Gonzalez Caldito has nothing to disclose.
Carmel Armon, MD, FAAN Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Inbal - Israeli Government Insurance Company. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurological Sciences. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Individual attorney offices. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Civil Courts. Dr. Armon has received publishing royalties from a publication relating to health care.
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Adrian Budhram, MD Dr. Budhram has nothing to disclose.
Dhanashri P. Miskin, MD Dr. Miskin has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Ahsan M. Naduvil Valappil, MD Dr. Naduvil Valappil has nothing to disclose.
Alejandra Gomez Alejandra Gomez has nothing to disclose.
Christine Meadows, MD Dr. Meadows has nothing to disclose.
Sridar Narayanan Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Narges Moghimi, MD Dr. Moghimi has nothing to disclose.
Pablo A. Lopez, MD No disclosure on file
Meryim Poursheykhi, MD Dr. Poursheykhi has nothing to disclose.
Mohammad N. Kayyali, MD Dr. Kayyali has nothing to disclose.
Enrique Gomez Figueroa, MD, MSc Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
NINA EAGLE NINA EAGLE has nothing to disclose.
Kenjiro Kunieda Kenjiro Kunieda has nothing to disclose.
Alfonso S. Lopez, MD Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Katherine M. Wojcicki, DO Dr. Wojcicki has nothing to disclose.
Annie S. Daniel, MBBS Dr. Daniel has nothing to disclose.
Vincent E. Zimmern, MD, MSc, MPH Dr. Zimmern has nothing to disclose.
Daniel A. Crespo, MD Dr. Crespo has nothing to disclose.
Srivadee Oravivattanakul, MD Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Leila Ghaffari, MD Dr. Ghaffari has nothing to disclose.
Carolyn Goldschmidt, DO Dr. Goldschmidt has nothing to disclose.
Hasnain Arshad, MD Dr. Arshad has nothing to disclose.
Shreyas Gangadhara, MD Dr. Gangadhara has nothing to disclose.
Emilio R. Garrido Sanabria, MD, PhD Dr. Garrido Sanabria has nothing to disclose.
Pooja S. Raibagkar, MD Dr. Raibagkar has nothing to disclose.
Nicholas L. Zalewski, MD Dr. Zalewski has nothing to disclose.
Mary Clare McKenna, MB BCh BAO PhD Dr. McKenna has nothing to disclose.
Hai Ethan Hoang, MD Dr. Hoang has nothing to disclose.
Bruno Giometto, MD Dr. Giometto has nothing to disclose.
Aida Risman, MD Dr. Risman has nothing to disclose.
Beatriz Thames, MD Dr. Thames has nothing to disclose.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Jonathan R. Galli, MD Dr. Galli has nothing to disclose.
Michael Sweeney, MD Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Thomas Leist, MD, PhD, FAAN Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Wittness with DHHS HRSA.
Denis T. Balaban, MD The institution of Dr. Balaban has received research support from Biogen.
Veronica Rivas Veronica Rivas has nothing to disclose.
Akshay Deepak, MD Dr. Deepak has nothing to disclose.
Paul M. Elsbernd, MD Dr. Elsbernd has nothing to disclose.
Joan Santamaria, MD Joan Santamaria, MD has nothing to disclose.
Valentina Stephen Joseph, MD Dr. Joseph has nothing to disclose.
Michelle Devine, MD The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AGRIMS. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Advances in Neurology. The institution of an immediate family member of Dr. Devine has received research support from Center of Individualized Medicine, Mayo Clinic.
Sreekanth Vemula No disclosure on file
Victor Wang, MD Dr. Wang has nothing to disclose.
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Mirla L. Avila, MD Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Edgar Patricio Correa Diaz, Sr., MD Dr. Correa Diaz has nothing to disclose.
Jennifer Lord, MD Dr. Lord has nothing to disclose.
Bruce A. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Iryna I. Bilous, MD, PhD Dr. Bilous has nothing to disclose.
Soon-Tae Lee, MD, PhD Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Autoimmune Encephalitis Alliance. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Kelsey M. Smith, MD The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Federica Boso Federica Boso has nothing to disclose.
Shailee S. Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Martha Mulvey No disclosure on file
Mahmoud A. AbdelRazek, MD Dr. AbdelRazek has nothing to disclose.
Abu Nasar No disclosure on file
Sang Kun Lee, MD Prof. Lee has nothing to disclose.
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.
Sanjay Sharma, MD Dr. Sharma has nothing to disclose.
Geetanjali S. Rathore, MD, FAAN Dr. Rathore has nothing to disclose.
Austin T. Momii, MD Dr. Momii has nothing to disclose.
Yoonhyuk Jang, MD, PhD Mr. Jang has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Nobuaki Yoshikura, MD, PhD Dr. Yoshikura has nothing to disclose.
David A. Marks, MD Dr. Marks has nothing to disclose.
Mu Ji Hwang, MD Dr. Hwang has nothing to disclose.
Anju Parthan Anju Parthan has received personal compensation for serving as an employee of Alexion. Anju Parthan has received personal compensation for serving as an employee of Alkermes. Anju Parthan has received stock or an ownership interest from Alexion.
Romain Marignier, MD, PhD Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HORIZON THERAPEUTICS. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Andrea S. Synowiec, DO, FAAN Dr. Synowiec has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Synowiec has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Synowiec has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Joost J. Smolders, MD, PhD The institution of Dr. Smolders has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. The institution of Dr. Smolders has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. The institution of Dr. Smolders has received research support from Merck.
Daniella Miller, MD Dr. Miller has nothing to disclose.
Edgar Carnero Contentti Edgar Carnero Contentti has nothing to disclose.
Toluwalase O. Tofade, MBBS Dr. Tofade has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
Eugenio Magni, MD Dr. Magni has nothing to disclose.
Andrea Pilotto Andrea Pilotto has nothing to disclose.
Aleksey Tadevosyan, MD Dr. Tadevosyan has nothing to disclose.
Reuben Beer, MBBS Dr. Beer has nothing to disclose.
Megan A. Hansen, MD Dr. Hansen has nothing to disclose.
James Fryer James Fryer has received intellectual property interests from a discovery or technology relating to health care.
Lawrence Cook, PhD The institution of Dr. Cook has received research support from CDC. The institution of Dr. Cook has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Cook has received research support from Utah Highway Safety Office. The institution of Dr. Cook has received research support from NIH.
Marian P. LaMonte, MD, MSN, FAAN Dr. LaMonte has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Christopher P. Eckstein, MD The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Amanda L. Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Tuba Rashid Khan, MD Dr. Rashid Khan has nothing to disclose.
John E. Greenlee, MD, FAAN Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Kathryn C. Elkins, MD Dr. Elkins has nothing to disclose.
Sarah Germaine, DO Dr. Germaine has nothing to disclose.
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Hakan AY, MD Dr. AY has received personal compensation for serving as an employee of Takeda.
Lynne P. Taylor, MD, FAAN Dr. Taylor has received publishing royalties from a publication relating to health care.
Ibis D. Soto, MD Dr. Soto has nothing to disclose.
Justin Kinsella, MD Dr. Kinsella has nothing to disclose.
Rob Durcan, MB, BCh, BAO Dr. Durcan has nothing to disclose.
Anusha Yeshokumar, MD Dr. Yeshokumar has nothing to disclose.
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Julio Vega, MD Dr. Vega has nothing to disclose.
Maria Shoaib, MD Dr. Shoaib has nothing to disclose.
Ammar Kheder, MD Dr. Kheder has nothing to disclose.
Amy Kunchok, MBBS Dr. Kunchok has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics . Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Maria B. Weimer, MD Dr. Weimer has nothing to disclose.
Rafia Jawed, MD Dr. Jawed has nothing to disclose.
Osama Khojah Osama Khojah has nothing to disclose.
Jonathan Sarezky, MD Dr. Sarezky has nothing to disclose.
Andy T. Lin, MD Dr. Lin has nothing to disclose.
Ameneh Zare Shahabadi, MD, MPH Dr. Zare Shahabadi has nothing to disclose.
Eric Stulberg, MD Dr. Stulberg has nothing to disclose.
Tracey Cho, MD, FAAN Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Shamik Bhattacharyya, MD, FAAN Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Emad R. Noor, MD Dr. Noor has nothing to disclose.
Alen Delic No disclosure on file
Jessica Choi, MD Dr. Choi has nothing to disclose.
Ruth-Ann Marrie, MD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Stefanie J. Rodenbeck, MD Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
Sonam C. Bhalla, MD Dr. Bhalla has nothing to disclose.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Nidhiben A. Anadani, MD Dr. Anadani has nothing to disclose.
Christopher S. Mizenko Mr. Mizenko has nothing to disclose.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Anastasia Zekeridou, MD, PhD, FAAN The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Rohini D. Samudralwar, MD Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Pitcha Chompoopong, MD Dr. Chompoopong has nothing to disclose.
Ann Oh Dr. Oh has nothing to disclose.
Leah Loerinc Miss Loerinc has nothing to disclose.
Hannah Zhao-Fleming, MD, PhD Dr. Zhao-Fleming has nothing to disclose.
Maria I. Reyes-Mantilla, MD Dr. Reyes-Mantilla has nothing to disclose.
Victoria Fernandez Victoria Fernandez has nothing to disclose.
Ram N. Narayan, MD Dr. Narayan has nothing to disclose.
Benison Keung, MD Dr. Keung has nothing to disclose.
Allison P. Navis, MD The institution of Dr. Navis has received research support from NIH Loan Repayment Program.
Josephine Gutierrez, MD No disclosure on file
Tripthi Sugumar, MD Dr. Sugumar has nothing to disclose.
Ho Jin Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprilbio, HanAll BioPharma, Viela Bio. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, Biogen, Celltrion, Eisai, Merck Serono, Novartis, Sanofi Genzyme, Teva-Handok. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Sara Carta, MD Dr. Carta has nothing to disclose.
Kimiharu Fuseya Kimiharu Fuseya has nothing to disclose.
Anna Jolley Ms. Jolley has nothing to disclose.
Eugenia Martinez-Hernandez, MD The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a travel and speaking honoraria with Biogen. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a travel honoraria with UCB.
Thomas R. Haven, PhD Dr. Haven has nothing to disclose.
Kara Stavros, MD, FAAN Dr. Stavros has nothing to disclose.
Karen P. Frei, MD The institution of Dr. Frei has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Clinical Parkinsonism and Related Disorders journal.
Marcelo Matiello, MD, FAAN Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Anza Zahid, MD, MBBS Dr. Zahid has nothing to disclose.
Amal Atrous, Jr. No disclosure on file
Melody Badii, MD Dr. Badii has nothing to disclose.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, Mitsubushi, UCB, Roche, Novartis, Amplo, Alexion, Chugai, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Chugai. Dr. Palace has stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,.Meddimune, argenx. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Laura E. Paul, MD Dr. Paul has nothing to disclose.
Valerie Jeanneret Lopez, MD Dr. Jeanneret Lopez has nothing to disclose.
Laura J. Wu, MD, PhD Dr. Wu has nothing to disclose.
Amputch Karukote, MD Dr. Karukote has nothing to disclose.
Gina S. Perez-Giraldo, MD Dr. Perez-Giraldo has nothing to disclose.
Aditi V. Varma-Doyle, MD Dr. Varma-Doyle has nothing to disclose.
Chokri A. Mhiri, MD Prof. Mhiri has received personal compensation for serving as an employee of Hikma. Prof. Mhiri has received personal compensation for serving as an employee of Sanofi Genzyme. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Mhiri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Kazuhiro Higashida Kazuhiro Higashida has nothing to disclose.
Adam F. Sitzmann, MD Dr. Sitzmann has nothing to disclose.
Xing Dai, MD Dr. Dai has nothing to disclose.
Shivani Naik, MD Dr. Naik has nothing to disclose.
Takashi Yamamura, MD Dr. Yamamura has nothing to disclose.
Grace Gombolay, MD Dr. Gombolay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. An immediate family member of Dr. Gombolay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Washington Injury Lawyers. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Ylec M. Cardenas Castillo, MD Dr. Cardenas Castillo has nothing to disclose.
Alessandro Padovani, MD No disclosure on file
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Alejandro E. Caride No disclosure on file
Erik K. St. Louis, MD Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Ritu Bagla, MD Dr. Bagla has nothing to disclose.
Maria Martinez-Lage, MD The institution of Dr. Martinez-Lage has received research support from NIH.
James E. Eaton III, MD Dr. Eaton has nothing to disclose.
Mohamed Diyab, MD, MBBS Dr. Diyab has nothing to disclose.
Sarah E. Berini, MD Dr. Berini has nothing to disclose.
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Jie Pan, MD Dr. Pan has nothing to disclose.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Michal Vytopil, MD Dr. Vytopil has nothing to disclose.
Bhaskar Roy, MD, FAAN Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.
Lisa K. Peterson, PhD The institution of Dr. Peterson has received research support from Kronus.
Jocelyn B. Lorenzo, MD Dr. Lorenzo has nothing to disclose.
LynnMarie Jarratt, MD Dr. Jarratt has nothing to disclose.
Jacob A. Sloane, MD, PhD Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Maryam Zulfiqar, MD Dr. Zulfiqar has nothing to disclose.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Elijah Lackey, MD Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
Carla Kim No disclosure on file
Daniela Stokmaier Daniela Stokmaier has received personal compensation for serving as an employee of Roche.
James M. Hillis, MD Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.
M. Tariq Bhatti, MD Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Suresh Chandran, MD Dr. Chandran has nothing to disclose.
Satyanarayana Gedela, MD Dr. Gedela has nothing to disclose.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Satheesh Kumar Bokka, MD No disclosure on file
M Bakri Hammami, MD Dr. Hammami has received intellectual property interests from a discovery or technology relating to health care.
Eati Basal Eati Basal has nothing to disclose.
Jeffrey Varghese Mr. Varghese has nothing to disclose.
Idaira Aguilar Tejedor, MD Dr. Aguilar Tejedor has nothing to disclose.
Yujie Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech.
Amir Adeli, MD Dr. Adeli has nothing to disclose.
Shyam Majmundar, MD Dr. Majmundar has nothing to disclose.
Christopher Hahn, MD Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylim.
William C. Hoffman No disclosure on file
Vanil Pandya, MD Dr. Pandya has nothing to disclose.
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
John C. Feemster, MD Mr. Feemster has nothing to disclose.
Vishwanath Sagi, MD, FAAN Dr. Sagi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Sagi has a non-compensated relationship as a President with Commonwealth Neurological Society that is relevant to AAN interests or activities.
Aparna M. Prabhu, MD Dr. Prabhu has nothing to disclose.
Maria Antonietta Mazzola, MD Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
Jenny Lin, MD Dr. Lin has nothing to disclose.
Katrina Roberto, MD Dr. Roberto has nothing to disclose.
Aminah Abdul Razzack Ms. Abdul Razzack has nothing to disclose.
Tzu-ying Chuang, MD, PhD Dr. Chuang has nothing to disclose.
Yanjun Guo, MD No disclosure on file
Pritikanta Paul, MD Dr. Paul has nothing to disclose.
Ingo Kleiter Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall.
Olivia Groover, MD Dr. Groover has nothing to disclose.
Akio Kimura, MD Dr. Kimura has nothing to disclose.
Praveen Hariharan, MD Dr. Hariharan has nothing to disclose.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
Osamah Alnasser, MD Dr. Alnasser has nothing to disclose.
Alex Exuzides Alex Exuzides has nothing to disclose.
Kiran Thakur, MD, FAAN Dr. Thakur has received personal compensation for serving as an employee of World Health Organization. Dr. Thakur has received personal compensation for serving as an employee of Pan American Health Organization. Dr. Thakur has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. The institution of Dr. Thakur has received research support from National Institute of Health.
Amy Hessler, DO, FAAN Dr. Hessler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie . Dr. Hessler has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Cristina Valencia Sanchez, MD Dr. Valencia Sanchez has nothing to disclose.
Helen G. Brown, MD Dr. Brown has nothing to disclose.
Saba Asif, MBBS Ms. Asif has nothing to disclose.
Jacinta Behne Ms. Behne has nothing to disclose.
Nusrat Ahsan, MD Dr. Ahsan has nothing to disclose.
Shankar Venkatasubramanian Dr. Venkatasubramanian has nothing to disclose.
Avi Gadoth, MD Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care.
Nancy Law Nancy Law has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Nancy Law has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Nancy Law has received personal compensation in the range of $500,000-$999,999 for serving as a CEO (Consultant) with Myasthenia Gravis Foundation of America. Nancy Law has a non-compensated relationship as a Board member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities.
Rachelle Dugue, MD, PhD Dr. Dugue has nothing to disclose.
Dylan T. Warfield, MD Mr. Warfield has nothing to disclose.
Shamima Akter, MD Dr. Akter has nothing to disclose.
Ahmer Asif, MD Dr. Asif has nothing to disclose.
Robyn Howarth No disclosure on file
Shaul Shaulov, MD Dr. Shaulov has nothing to disclose.
Terry Smith Terry Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Horizon. Terry Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunovant. Terry Smith has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Terry Smith has received intellectual property interests from a discovery or technology relating to health care.
Carrie Carr Carrie Carr has nothing to disclose.
Yakov Shaulov, MD Dr. Shaulov has nothing to disclose.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from Biogen. The institution of Dr. Yeh has received research support from Stem Cell Network. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from Ontario Institute for Regenerative Medicine. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from NIH. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from CMSC. The institution of Dr. Yeh has received research support from MSSC.
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Stefan Blum, PhD, FRACP The institution of Dr. Blum has received research support from Merck. The institution of Dr. Blum has received research support from MSRA. The institution of Dr. Blum has received research support from PA Research Foundation.
Saeed Alghamdi, MD Dr. Alghamdi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for boehringer ingelheim.
Daniela A. Pimentel Maldonado, MD, MSCR Dr. Pimentel Maldonado has nothing to disclose.
Daniel H. Lachance, MD, FAAN Dr. Lachance has nothing to disclose.
Yifat Alcalay Yifat Alcalay has nothing to disclose.
Jennifer P. Rubin, MD Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio.
Martineau Louine, MD Dr. Louine has nothing to disclose.
Hiroya Ohara, MD Dr. Ohara has nothing to disclose.
Bryan E. Tsao, MD, FAAN Dr. Tsao has received publishing royalties from a publication relating to health care.
Andrew Klink No disclosure on file
Timothy J. Ainger, PhD Dr. Ainger has nothing to disclose.
Eileen Harrigan, MD Dr. Harrigan has nothing to disclose.
Diana Greene-Chandos, MD Dr. Greene-Chandos has nothing to disclose.
Ahmad Mahadeen, MD Dr. Mahadeen has nothing to disclose.
Han Sang Lee No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Mar Guasp, MD Dr. Guasp has nothing to disclose.
Bing Liao, MD Dr. Liao has nothing to disclose.
Joseph D. Burns, MD Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Mariyam Humayun, MD Dr. Humayun has nothing to disclose.
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Yuichi Hayashi Yuichi Hayashi has nothing to disclose.
Marvin Van Luijn The institution of Marvin Van Luijn has received research support from Merck.
Frederick Bassal, DO Dr. Bassal has nothing to disclose.
Dev Mehta, DO Dr. Mehta has nothing to disclose.
Robert W. Charlson, MD Dr. Charlson has nothing to disclose.
Ahmed K. Harazeen, MBBS Dr. Harazeen has nothing to disclose.
Bart Chwalisz, MD Dr. Chwalisz has nothing to disclose.
Alexis E. Brantley Alexis Brantley has nothing to disclose.
Elochukwu Ibekwe, MD Dr. Ibekwe has nothing to disclose.
Yael Paran No disclosure on file
Yasir N. Jassam, MD, MRCP, FAAN Dr. Jassam has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Jassam has received research support from Roche, Chugai Pharmaceutical MedImmune LLC.Novartis, MedDay. Actelion, Alexion Pharmaceuticals,TG Therapeutics Alexion Pharmaceuticals, Teva Pharmaceuticals, Genentech phamarcetucal companies..